SVCM
ATXS

Saturn V Capital Management’s Astria Therapeutics ATXS Stock Holding History

Saturn V Capital Management’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-990,663
Closed -$7.61M – 24
2023
Q4 		$7.61M Sell
990,663
-228,430
-19% -$1.26M 2.91% 15
2023
Q3 		$9.09M Buy
1,219,093
+581,236
+91% +$4.96M 3.81% 15
2023
Q2 		$5.31M Buy
637,857
+536,518
+529% +$6.19M 2.95% 16
2023
Q1 		$1.35M Sell
101,339
-68,154
-40% -$921K 1.01% 17
2022
Q4 		$1.56M Buy
+169,493
New +$1.75M 1.29% 18

Other funds holding ATXS

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return